A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...
Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.
Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have ...
Discover how global tariffs are driving changes in medtech growth strategies, M&A activities, and manufacturing footprints.
India is witnessing a surge in MedTech startups, yet many are playing it safe by focusing on low-risk innovations. Experts call for bold, high-tech investments to drive disruption in the medtech field ...
Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...
Med-tech companies looking for capital will have to work harder this year to attract investor attention. Even though investment firms have money to deploy, the capital will go toward more targeted ...
While in 2025 med-tech financings averaged $3.3 billion per month, January 2026 saw the sector bring in $1.52 billion across 39 transactions. It was the lowest monthly total since November 2024’s $924 ...
At MD&M West 2026, Critical Manufacturing showcases a platform that converges MES, analytics and AI to power data-driven ...
Aztron Medtech, a privately held orthopedic device company, today announced that more than 100 clinical procedures have now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results